Helsinn Advanced Synthesis opens its largest dedicated Anticancer bay

30 July 2020

3B Future Health Fund announces new investment in iOnctura

14 July 2020

FONDAZIONE IBSA: AL VIA IL BANDO 2020 PER LE 5 BORSE DI STUDIO ANNUALI

25 June 2020

Helsinn Group supports Conquer Cancer, the ASCO Foundation’s COVID Impacts Cancer fund

10 June 2020

Helsinn announces launch of oral formulation of Akynzeo® in China

9 June 2020

Helsinn announces FDA acceptance of IND application for TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities

8 June 2020

Helsinn Group announces FDA approval of a new liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) injection in the United States

2 June 2020

Open Accelerator: the international program for start-ups in Life Science is back with a new Call for Solutions

26 May 2020

Linnea appoints Susanne Caspar CEO

20 May 2020

DA IBSA OLTRE 700.000 CHF PER COMBATTERE L’EMERGENZA COVID-19 DI QUESTI 245.000 CHF DONATI DAI LAVORATORI IBSA A SOSTEGNO DELLE FAMIGLIE IN DIFFICOLTÀ

13 May 2020